Form 8-K - Current report:
SEC Accession No. 0001493152-24-022769
Filing Date
2024-06-05
Accepted
2024-06-05 16:35:13
Documents
17
Period of Report
2024-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53229
2 ex10-2.htm EX-10.2 1926
3 ex10-2_001.jpg GRAPHIC 147226
4 ex10-2_002.jpg GRAPHIC 12291
  Complete submission text file 0001493152-24-022769.txt   503315

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vhaqw-20240512.xsd EX-101.SCH 3637
6 XBRL DEFINITION FILE vhaqw-20240512_def.xml EX-101.DEF 27198
7 XBRL LABEL FILE vhaqw-20240512_lab.xml EX-101.LAB 37395
8 XBRL PRESENTATION FILE vhaqw-20240512_pre.xml EX-101.PRE 25814
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7193
Mailing Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326
Business Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 241022457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)